Patients with treatment-refractory irritable bowel syndrome (IBS) with predominant bloating may fare well with faecal microbiota transplantation (FMT), which has been shown in a study to induce symptom relief. However, the beneficial effects wane over 1 year, and a second FMD appears to re-establish the benefits but only in those who have shown a prior response.
Use of cannabis or cannabinoids among patients with inflammatory bowel disease (IBD) does little to induce clinical remission or reduce inflammation, although it helps calm patient-reported symptoms and improve quality of life, a study has found.
The low rate of retransplantation in patients with recurring autoimmune hepatitis (AIH) is partly to blame for the greater post-transplant mortality in this population compared with other autoimmune liver disease, suggests a recent study.
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
In the first year following percutaneous coronary intervention for acute coronary syndrome, ticagrelor and prasugrel cuts the risk of gastrointestinal (GI) bleeding by more than 30 percent compared with clopidogrel, as shown in a large real-world study.